IGF1 Gilthead Seabream

IGF1 Gilthead Seabream Recombinant

Recombinant IGF1 Gilthead Seabream, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 68 amino acids. It has a molecular weight of 7545.4 Daltons and a predicted isoelectric point (pI) of 7.72. The purification of IGF-1 is achieved using proprietary chromatographic methods.

Shipped with Ice Packs
Cat. No.
BT17466
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

IGF1 Human

IGF-1 Human Recombinant

Recombinant Human IGF1 produced in E. coli is a single, non-glycosylated polypeptide chain consisting of 70 amino acids. It has a molecular weight of 7.6 kDa. The purification of IGF-1 is achieved using proprietary chromatographic methods.

Shipped with Ice Packs
Cat. No.
BT17540
Source
Escherichia Coli. 
Appearance
Sterile Filtered White Lyophilized Powder

IGF1 Human Des1-3

Insulin-Like Growth Factor 1 Des (1-3) Human Recombinant

IGF-I Des(1-3) Human Recombinant, produced in E. Coli, is a single, non-glycosylated polypeptide chain consisting of 67 amino acids (aa 4-70) with a molecular mass of 7368.5 Daltons. The purification of IGF-1 Des1-3 is achieved using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17632
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized powder.

IGF1 Human, A67T

Insulin Like Growth Factor-1, Mutant A67T Human Recombinant

IGF1 A67T Human Recombinant, produced in E. coli, is a single, non-glycosylated polypeptide chain containing 70 amino acids with an approximate molecular mass of 7.7 kDa. The purification process of IGF1 A67T involves proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17690
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

IGF1 Human, A70T

Insulin Like Growth Factor-1, Mutant A70T Human Recombinant

IGF1 A70T Human Recombinant, produced in E. coli, is a single, non-glycosylated polypeptide chain composed of 70 amino acids with an approximate molecular mass of 7.7kDa. The purification of IGF1 A70T is achieved using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17776
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized powder.

IGF1 Human, GST

Insulin-Like Growth Factor 1 Human Recombinant, GST Tag

Recombinant Human IGF1 is a single, non-glycosylated polypeptide chain expressed in E. coli. It is fused to a GST tag and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17850
Source
Escherichia Coli.
Appearance
A sterile, clear, and colorless solution.

IGFBP4 Sf9, Human

Insulin Like Growth Factor Binding Protein-4 Human Recombinant, Sf9

Recombinant Human Insulin Like Growth Factor Binding Protein-4, produced in Sf9 Insect cells, is a single, glycosylated polypeptide chain. It comprises 237 amino acids, resulting in a molecular mass of 30kDa. The purification of IGFBP4 is achieved using proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT18674
Source

Sf9, Insect cells.

Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

LR3 IGF1 Human

LR3 Insulin Like Growth Factor-1 Human Recombinant

LR3 is a long-acting analog of human IGF-1 engineered for mammalian cell culture, supporting large-scale biopharmaceutical production. This recombinant human LR3 Insulin Like Growth Factor-1, produced in E. coli, is a single, non-glycosylated polypeptide chain with 83 amino acids and a molecular weight of 9.1 kDa.
Shipped with Ice Packs
Cat. No.
BT18739
Source
Escherichia Coli.
Appearance
White, sterile-filtered powder obtained by lyophilization.

pro-IGF2 Human

Pro-Insulin Like Growth Factor-2 Human Recombinant

Recombinant Human Pro-IGF2, expressed in HEK cells, is a glycosylated monomeric protein. It comprises 157 amino acids (residues 24-180), resulting in a total molecular weight of 25 kDa. Pro-IGF2 includes a C-terminal propeptide (E peptide) spanning from Arg92 to Lys180. The protein undergoes purification using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT18848
Source
HEK.
Appearance
The product appears as a sterile, filtered, white, lyophilized (freeze-dried) powder.
Definition and Classification

Insulin-like growth factors (IGFs) are proteins with high sequence similarity to insulin. They are part of a complex system that cells use to communicate with their physiological environment. This system includes two main types of IGFs: IGF-1 and IGF-2. IGF-1 is primarily involved in growth and development, while IGF-2 is crucial for fetal development .

Biological Properties

Key Biological Properties: IGFs are involved in cell proliferation, differentiation, and survival. They play a significant role in regulating normal physiology and various pathological states, including cancer .

Expression Patterns: IGF-1 is mainly secreted by the liver in response to growth hormone (GH) stimulation. IGF-2 is primarily involved in fetal development and is expressed in various tissues .

Tissue Distribution: IGFs are found in many tissues, including the liver, brain, and kidneys. They are also present in the blood, where they are bound to IGF-binding proteins (IGFBPs) that regulate their activity .

Biological Functions

Primary Biological Functions: IGFs are essential for growth and development. IGF-1 promotes cell proliferation and inhibits apoptosis (cell death), while IGF-2 is crucial for early development .

Role in Immune Responses and Pathogen Recognition: IGFs have been shown to play roles in immune responses, although their exact mechanisms in pathogen recognition are still being studied .

Modes of Action

Mechanisms with Other Molecules and Cells: IGFs exert their effects by binding to the IGF-1 receptor (IGF1R), which triggers a cascade of intracellular signaling pathways, including the MAPK and PI3K pathways .

Binding Partners: IGFs bind to IGF1R with high affinity. They can also bind to insulin receptors and IGF-2 receptors, although with lower affinity .

Downstream Signaling Cascades: Upon binding to IGF1R, IGFs activate several downstream signaling cascades that promote cell growth, survival, and differentiation .

Regulatory Mechanisms

Expression and Activity Control: The expression of IGFs is regulated by growth hormone (GH) and other factors such as nutrition, stress, and exercise .

Transcriptional Regulation: IGF genes are regulated at the transcriptional level by various transcription factors and hormones .

Post-Translational Modifications: IGFs undergo post-translational modifications, including phosphorylation and glycosylation, which affect their stability and activity .

Applications

Biomedical Research: IGFs are widely studied in biomedical research for their roles in growth, development, and disease .

Diagnostic Tools: IGF levels are measured as biomarkers for growth disorders and certain cancers .

Therapeutic Strategies: IGF analogs and inhibitors are being developed as potential therapies for growth deficiencies and cancer .

Role in the Life Cycle

Development: IGFs are crucial for fetal development and growth during childhood .

Aging: IGF levels decline with age, which is associated with reduced muscle mass and increased risk of age-related diseases .

Disease: Dysregulation of IGF signaling is linked to various diseases, including cancer, diabetes, and neurodegenerative disorders .

© Copyright 2024 Thebiotek. All Rights Reserved.